| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | integrin binding | CDH26 COL16A1 LAMA5 LAMB1 ITGA2B ITGA7 ITGAD ITGAX THBS1 FBN1 LTBP4 | 6.61e-07 | 175 | 183 | 11 | GO:0005178 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.68e-05 | 130 | 183 | 8 | GO:0005200 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | HBS1L GTPBP6 TUBA3D TUBA1C TUBA3E TUBA8 CHM TUBA4A TUBA3C SH3BP4 TUBA1B RND1 TUBA1A DNM3 | 5.58e-05 | 439 | 183 | 14 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | HBS1L GTPBP6 TUBA3D TUBA1C TUBA3E TUBA8 CHM TUBA4A TUBA3C SH3BP4 TUBA1B RND1 TUBA1A DNM3 | 5.58e-05 | 439 | 183 | 14 | GO:0019001 |
| GeneOntologyMolecularFunction | cysteine-type endopeptidase activity | 1.40e-04 | 86 | 183 | 6 | GO:0004197 | |
| GeneOntologyMolecularFunction | GTP binding | HBS1L GTPBP6 TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B RND1 TUBA1A DNM3 | 3.12e-04 | 397 | 183 | 12 | GO:0005525 |
| GeneOntologyCellularComponent | microtubule | TUBA3D TUBA1C CASP1 WHAMM TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B PARP4 TUBA1A DNM3 CEP295 CKAP2 DNAH8 | 6.55e-05 | 533 | 181 | 15 | GO:0005874 |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.58e-04 | 59 | 181 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | integrin complex | 1.62e-04 | 32 | 181 | 4 | GO:0008305 | |
| GeneOntologyCellularComponent | laminin-10 complex | 2.22e-04 | 3 | 181 | 2 | GO:0043259 | |
| GeneOntologyCellularComponent | supramolecular fiber | CASP14 TUBA3D TUBA1C OBSCN CASP1 OBSL1 WHAMM TUBA3E KLHL41 TUBA8 TUBA4A TUBA3C TUBA1B PARP4 FBN1 TUBA1A UNC45B DNM3 CEP295 CKAP2 LTBP4 DNAH8 | 5.70e-04 | 1179 | 181 | 22 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CASP14 TUBA3D TUBA1C OBSCN CASP1 OBSL1 WHAMM TUBA3E KLHL41 TUBA8 TUBA4A TUBA3C TUBA1B PARP4 FBN1 TUBA1A UNC45B DNM3 CEP295 CKAP2 LTBP4 DNAH8 | 6.24e-04 | 1187 | 181 | 22 | GO:0099081 |
| Domain | Alpha_tubulin | 2.53e-13 | 9 | 181 | 7 | IPR002452 | |
| Domain | Tubulin_C | 1.08e-09 | 22 | 181 | 7 | PF03953 | |
| Domain | Tubulin/FtsZ_2-layer-sand-dom | 1.08e-09 | 22 | 181 | 7 | IPR018316 | |
| Domain | Tubulin_C | 1.08e-09 | 22 | 181 | 7 | SM00865 | |
| Domain | Tub_FtsZ_C | 1.54e-09 | 23 | 181 | 7 | IPR008280 | |
| Domain | Tubulin_C | 1.54e-09 | 23 | 181 | 7 | IPR023123 | |
| Domain | TUBULIN | 1.54e-09 | 23 | 181 | 7 | PS00227 | |
| Domain | Tubulin | 1.54e-09 | 23 | 181 | 7 | IPR000217 | |
| Domain | Tubulin | 1.54e-09 | 23 | 181 | 7 | SM00864 | |
| Domain | Tubulin_CS | 1.54e-09 | 23 | 181 | 7 | IPR017975 | |
| Domain | Tubulin_FtsZ_GTPase | 2.15e-09 | 24 | 181 | 7 | IPR003008 | |
| Domain | Tubulin | 2.15e-09 | 24 | 181 | 7 | PF00091 | |
| Domain | - | 2.64e-08 | 20 | 181 | 6 | 3.30.1330.20 | |
| Domain | - | 3.67e-08 | 21 | 181 | 6 | 1.10.287.600 | |
| Domain | - | 5.00e-08 | 22 | 181 | 6 | 3.40.50.1440 | |
| Domain | Integrin_alpha | 2.67e-06 | 11 | 181 | 4 | PF00357 | |
| Domain | Integrin_alpha_C_CS | 1.42e-05 | 16 | 181 | 4 | IPR018184 | |
| Domain | Integrin_alpha-2 | 2.35e-05 | 18 | 181 | 4 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 2.35e-05 | 18 | 181 | 4 | PS00242 | |
| Domain | Integrin_alpha2 | 2.35e-05 | 18 | 181 | 4 | PF08441 | |
| Domain | Integrin_alpha | 2.35e-05 | 18 | 181 | 4 | IPR000413 | |
| Domain | Int_alpha | 2.95e-05 | 19 | 181 | 4 | SM00191 | |
| Domain | Int_alpha_beta-p | 2.95e-05 | 19 | 181 | 4 | IPR013519 | |
| Domain | FG_GAP | 5.44e-05 | 22 | 181 | 4 | PS51470 | |
| Domain | HEAT_REPEAT | 5.98e-05 | 70 | 181 | 6 | PS50077 | |
| Domain | FG-GAP | 7.79e-05 | 24 | 181 | 4 | PF01839 | |
| Domain | FG-GAP | 7.79e-05 | 24 | 181 | 4 | IPR013517 | |
| Domain | Integrin_dom | 9.20e-05 | 25 | 181 | 4 | IPR032695 | |
| Domain | TRPV5/TRPV6 | 9.34e-05 | 2 | 181 | 2 | IPR008344 | |
| Domain | HEAT | 9.88e-05 | 48 | 181 | 5 | PF02985 | |
| Domain | Ion_trans_dom | 1.23e-04 | 114 | 181 | 7 | IPR005821 | |
| Domain | Ion_trans | 1.23e-04 | 114 | 181 | 7 | PF00520 | |
| Domain | CASPASE_HIS | 1.39e-04 | 11 | 181 | 3 | PS01121 | |
| Domain | Caspase_his_AS | 1.85e-04 | 12 | 181 | 3 | IPR016129 | |
| Domain | CASPASE_CYS | 1.85e-04 | 12 | 181 | 3 | PS01122 | |
| Domain | Pept_C14_p10 | 1.85e-04 | 12 | 181 | 3 | IPR002138 | |
| Domain | Caspase_cys_AS | 1.85e-04 | 12 | 181 | 3 | IPR033139 | |
| Domain | CASPASE_P10 | 1.85e-04 | 12 | 181 | 3 | PS50207 | |
| Domain | CASc | 2.38e-04 | 13 | 181 | 3 | SM00115 | |
| Domain | Pept_C14A | 2.38e-04 | 13 | 181 | 3 | IPR015917 | |
| Domain | HEAT | 2.45e-04 | 58 | 181 | 5 | IPR000357 | |
| Domain | Serum_albumin/AFP/Afamin | 2.78e-04 | 3 | 181 | 2 | IPR021177 | |
| Domain | Requiem/DPF_N_dom | 2.78e-04 | 3 | 181 | 2 | IPR025750 | |
| Domain | Requiem_N | 2.78e-04 | 3 | 181 | 2 | PF14051 | |
| Domain | - | 3.01e-04 | 14 | 181 | 3 | 3.40.50.1460 | |
| Domain | Pept_C14_p20 | 3.01e-04 | 14 | 181 | 3 | IPR001309 | |
| Domain | Caspase-like_dom | 3.01e-04 | 14 | 181 | 3 | IPR029030 | |
| Domain | CASPASE_P20 | 3.01e-04 | 14 | 181 | 3 | PS50208 | |
| Domain | - | 3.25e-04 | 95 | 181 | 6 | 2.60.120.200 | |
| Domain | ARM-type_fold | NCAPD3 ATR BTAF1 ITPR2 VAC14 URB1 PLAA UNC45B RIC8A HTT TANGO6 | 4.85e-04 | 339 | 181 | 11 | IPR016024 |
| Domain | ALBUMIN | 5.53e-04 | 4 | 181 | 2 | SM00103 | |
| Domain | Serum_albumin_N | 5.53e-04 | 4 | 181 | 2 | IPR014760 | |
| Domain | Serum_albumin_CS | 5.53e-04 | 4 | 181 | 2 | IPR020857 | |
| Domain | ALBUMIN_2 | 5.53e-04 | 4 | 181 | 2 | PS51438 | |
| Domain | ALBUMIN_1 | 5.53e-04 | 4 | 181 | 2 | PS00212 | |
| Domain | Serum_albumin | 5.53e-04 | 4 | 181 | 2 | PF00273 | |
| Domain | PHD | 8.07e-04 | 75 | 181 | 5 | PF00628 | |
| Domain | GHMP_kinases_C | 9.16e-04 | 5 | 181 | 2 | PF08544 | |
| Domain | Serum_albumin-like | 9.16e-04 | 5 | 181 | 2 | IPR020858 | |
| Domain | GHMP_kinase_C_dom | 9.16e-04 | 5 | 181 | 2 | IPR013750 | |
| Domain | GHMP_kinase_N_dom | 9.16e-04 | 5 | 181 | 2 | IPR006204 | |
| Domain | GHMP_kinases_N | 9.16e-04 | 5 | 181 | 2 | PF00288 | |
| Domain | - | 9.16e-04 | 5 | 181 | 2 | 3.30.70.890 | |
| Domain | Znf_PHD-finger | 1.02e-03 | 79 | 181 | 5 | IPR019787 | |
| Domain | IQ | 1.14e-03 | 81 | 181 | 5 | SM00015 | |
| Domain | ARM-like | 1.31e-03 | 270 | 181 | 9 | IPR011989 | |
| Domain | ALB/AFP/VDB | 1.37e-03 | 6 | 181 | 2 | IPR000264 | |
| Domain | - | 1.48e-03 | 222 | 181 | 8 | 1.25.10.10 | |
| Domain | PHD | 1.74e-03 | 89 | 181 | 5 | SM00249 | |
| Domain | Cadherin_C | 1.76e-03 | 25 | 181 | 3 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 1.76e-03 | 25 | 181 | 3 | IPR000233 | |
| Domain | IQ_motif_EF-hand-BS | 1.83e-03 | 90 | 181 | 5 | IPR000048 | |
| Domain | APC_su10/DOC_dom | 1.90e-03 | 7 | 181 | 2 | IPR004939 | |
| Domain | Desmosomal_cadherin | 1.90e-03 | 7 | 181 | 2 | IPR009122 | |
| Domain | TB | 1.90e-03 | 7 | 181 | 2 | PF00683 | |
| Domain | DOC | 1.90e-03 | 7 | 181 | 2 | PS51284 | |
| Domain | ANAPC10 | 1.90e-03 | 7 | 181 | 2 | PF03256 | |
| Domain | APC10 | 1.90e-03 | 7 | 181 | 2 | SM01337 | |
| Domain | Znf_PHD | 1.92e-03 | 91 | 181 | 5 | IPR001965 | |
| Domain | IQ | 2.11e-03 | 93 | 181 | 5 | PS50096 | |
| Domain | ZF_PHD_2 | 2.32e-03 | 95 | 181 | 5 | PS50016 | |
| Domain | Laminin_G | 2.41e-03 | 58 | 181 | 4 | IPR001791 | |
| Domain | ZF_PHD_1 | 2.43e-03 | 96 | 181 | 5 | PS01359 | |
| Domain | - | TTF2 HBS1L NWD1 GTPBP6 MYO19 CMPK2 CHD9 CARD10 BTAF1 DICER1 RND1 ATAD2B DNM3 WSCD2 DHX34 DNAH8 | 2.51e-03 | 746 | 181 | 16 | 3.40.50.300 |
| Domain | - | 2.52e-03 | 8 | 181 | 2 | 3.90.290.10 | |
| Domain | Cadherin_pro | 2.52e-03 | 8 | 181 | 2 | SM01055 | |
| Domain | Cadherin_pro_dom | 2.52e-03 | 8 | 181 | 2 | IPR014868 | |
| Domain | Catenin_binding_dom | 2.72e-03 | 29 | 181 | 3 | IPR027397 | |
| Domain | - | 2.72e-03 | 29 | 181 | 3 | 4.10.900.10 | |
| Domain | Znf_FYVE_PHD | 3.12e-03 | 147 | 181 | 6 | IPR011011 | |
| Domain | TB_dom | 3.22e-03 | 9 | 181 | 2 | IPR017878 | |
| Domain | TB | 3.22e-03 | 9 | 181 | 2 | PS51364 | |
| Domain | SNF2_N | 3.61e-03 | 32 | 181 | 3 | IPR000330 | |
| Domain | SNF2_N | 3.61e-03 | 32 | 181 | 3 | PF00176 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.85e-12 | 17 | 141 | 8 | M47768 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT | 2.09e-12 | 26 | 141 | 9 | M47672 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT | 3.30e-12 | 18 | 141 | 8 | M47753 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.65e-12 | 19 | 141 | 8 | M47818 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.65e-12 | 19 | 141 | 8 | M47813 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT | 9.34e-12 | 20 | 141 | 8 | M47890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS | 9.34e-12 | 20 | 141 | 8 | M47911 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.50e-11 | 21 | 141 | 8 | M27067 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY | 1.50e-11 | 21 | 141 | 8 | M47767 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DNAH8 HTT | 1.72e-11 | 45 | 141 | 10 | M47670 |
| Pathway | KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH | 2.33e-11 | 22 | 141 | 8 | M47903 | |
| Pathway | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | 3.54e-11 | 23 | 141 | 8 | M19135 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION | 3.54e-11 | 23 | 141 | 8 | M47910 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION | 3.54e-11 | 23 | 141 | 8 | M47900 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT | 5.27e-11 | 24 | 141 | 8 | M47671 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 5.27e-11 | 24 | 141 | 8 | M47700 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 7.69e-11 | 25 | 141 | 8 | M47775 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT | 7.69e-11 | 25 | 141 | 8 | M47710 | |
| Pathway | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | 1.10e-10 | 26 | 141 | 8 | M9648 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION | 2.15e-10 | 28 | 141 | 8 | M47898 | |
| Pathway | REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS | 2.95e-10 | 29 | 141 | 8 | M27948 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A DNAH8 | 3.27e-10 | 43 | 141 | 9 | M47669 |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 7.05e-10 | 32 | 141 | 8 | M29848 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 7.05e-10 | 32 | 141 | 8 | M27491 | |
| Pathway | REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING | 9.22e-10 | 33 | 141 | 8 | M27297 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION | 9.22e-10 | 33 | 141 | 8 | M47901 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 1.13e-09 | 49 | 141 | 9 | M891 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT | 1.54e-09 | 35 | 141 | 8 | M47774 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | TUBA3D TUBA1C LAMB1 TUBA3E ITGA2B TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A SCN4A DNM3 | 2.89e-09 | 121 | 141 | 12 | M872 |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 3.11e-09 | 38 | 141 | 8 | M14981 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT | 8.86e-09 | 43 | 141 | 8 | M47773 | |
| Pathway | REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE | 1.02e-08 | 17 | 141 | 6 | MM14731 | |
| Pathway | REACTOME_AGGREPHAGY | 1.07e-08 | 44 | 141 | 8 | M29830 | |
| Pathway | REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS | 1.07e-08 | 44 | 141 | 8 | M27934 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 1.55e-08 | 46 | 141 | 8 | M27828 | |
| Pathway | WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY | TUBA3D TUBA1C CASP1 TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 3.41e-08 | 71 | 141 | 9 | M39690 |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 3.64e-08 | 51 | 141 | 8 | M26972 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 4.98e-08 | 53 | 141 | 8 | M27651 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B FANCG TUBA1A | 6.26e-08 | 76 | 141 | 9 | M48037 |
| Pathway | WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 6.72e-08 | 55 | 141 | 8 | M39613 | |
| Pathway | REACTOME_RECYCLING_PATHWAY_OF_L1 | 6.91e-08 | 37 | 141 | 7 | MM15102 | |
| Pathway | KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION | 7.78e-08 | 56 | 141 | 8 | M2333 | |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 8.97e-08 | 57 | 141 | 8 | M27251 | |
| Pathway | REACTOME_KINESINS | 1.55e-07 | 61 | 141 | 8 | M977 | |
| Pathway | REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN | 2.24e-07 | 27 | 141 | 6 | MM15549 | |
| Pathway | REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III | 2.24e-07 | 27 | 141 | 6 | MM15674 | |
| Pathway | KEGG_GAP_JUNCTION | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C ITPR2 TUBA1B TUBA1A | 2.75e-07 | 90 | 141 | 9 | M4013 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS | 3.54e-07 | 29 | 141 | 6 | MM15219 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.66e-07 | 68 | 141 | 8 | MM14968 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | TUBA3D TUBA1C PPM1E TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 4.01e-07 | 94 | 141 | 9 | M2843 |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 5.73e-07 | 72 | 141 | 8 | M26954 | |
| Pathway | REACTOME_PROTEIN_FOLDING | TUBA3D TUBA1C TUBA3E FBXW2 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A | 5.74e-07 | 98 | 141 | 9 | M776 |
| Pathway | REACTOME_GAP_JUNCTION_ASSEMBLY | 6.58e-07 | 32 | 141 | 6 | MM14730 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 8.07e-07 | 102 | 141 | 9 | M27648 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 8.73e-07 | 76 | 141 | 8 | M27215 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 1.18e-06 | 79 | 141 | 8 | M27743 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 1.28e-06 | 20 | 141 | 5 | MM1383 | |
| Pathway | REACTOME_AGGREPHAGY | 1.37e-06 | 36 | 141 | 6 | MM15669 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | PHYKPL COL16A1 ADAMTS2 LAMA5 LAMB1 ITGA2B ITGA7 ITGAD ITGAX BGN THBS1 FBN1 CAPN5 LTBP4 | 1.85e-06 | 300 | 141 | 14 | M610 |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 3.19e-06 | 90 | 141 | 8 | M29841 | |
| Pathway | REACTOME_PKR_MEDIATED_SIGNALING | 4.11e-06 | 66 | 141 | 7 | MM17074 | |
| Pathway | REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION | 4.65e-06 | 44 | 141 | 6 | MM14606 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 4.74e-06 | 126 | 141 | 9 | M705 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 4.80e-06 | 95 | 141 | 8 | M6729 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 5.06e-06 | 127 | 141 | 9 | M27181 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 5.19e-06 | 96 | 141 | 8 | M39581 | |
| Pathway | REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 7.04e-06 | 100 | 141 | 8 | M27650 | |
| Pathway | REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC | 7.82e-06 | 48 | 141 | 6 | MM15353 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | PHYKPL COL16A1 ADAMTS2 ITGA2B ITGA7 ITGAD ITGAX BGN THBS1 FBN1 CAPN5 LTBP4 | 1.08e-05 | 258 | 141 | 12 | MM14572 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.12e-05 | 140 | 141 | 9 | M27550 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | TUBA3D TUBA1C CD55 NEU3 TUBA3E TUBA8 TUBA4A TUBA3C GFPT1 TUBA1B TUBA1A MVD PMM2 | 1.25e-05 | 307 | 141 | 13 | M894 |
| Pathway | REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND | 1.26e-05 | 52 | 141 | 6 | MM14949 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 1.57e-05 | 54 | 141 | 6 | M27482 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B FANCG TUBA1A | 2.06e-05 | 151 | 141 | 9 | M550 |
| Pathway | REACTOME_KINESINS | 2.15e-05 | 57 | 141 | 6 | MM15714 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.22e-05 | 85 | 141 | 7 | M16441 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 2.66e-05 | 156 | 141 | 9 | M27097 | |
| Pathway | REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC | TUBA3D TUBA1C TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B IGF2R TUBA1A VPS51 | 3.69e-05 | 203 | 141 | 10 | M27654 |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 4.28e-05 | 94 | 141 | 7 | MM14515 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY | 5.92e-05 | 68 | 141 | 6 | MM14921 | |
| Pathway | REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT | 5.93e-05 | 134 | 141 | 8 | M27751 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | TUBA3D TUBA1C ITGA2B TUBA8 TUBA4A GFRA3 TUBA1B RND1 TUBA1A DNM3 PLXNA1 | 6.25e-05 | 261 | 141 | 11 | MM15676 |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 7.30e-05 | 138 | 141 | 8 | M29805 | |
| Pathway | REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT | 8.84e-05 | 73 | 141 | 6 | MM15491 | |
| Pathway | REACTOME_SELECTIVE_AUTOPHAGY | 8.84e-05 | 73 | 141 | 6 | MM15672 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | TUBA3D TUBA1C TUBA3E IRF4 TUBA8 TUBA4A TUBA3C TUBA1B FANCG TUBA1A EGR1 | 9.34e-05 | 273 | 141 | 11 | M983 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP23 TUBA3D MYO19 TUBA1C OBSCN WHAMM TUBA3E NSL1 GIT2 PLEKHG2 TUBA8 TUBA4A TUBA3C TUBA1B RND1 TUBA1A ARHGEF1 ARHGAP20 PLXNA1 | 1.00e-04 | 720 | 141 | 19 | M41838 |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 1.09e-04 | 187 | 141 | 9 | M961 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.11e-04 | 76 | 141 | 6 | MM14867 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.11e-04 | 76 | 141 | 6 | M27219 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 1.16e-04 | 110 | 141 | 7 | MM15350 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 1.21e-04 | 26 | 141 | 4 | M47 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 1.28e-04 | 191 | 141 | 9 | M29614 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | CASP14 DSC3 DSG3 TUBA3D TUBA1C ITGA2B TUBA8 TUBA4A GFRA3 TUBA1B RND1 TUBA1A MITF DNM3 PLXNA1 | 1.51e-04 | 502 | 141 | 15 | MM14537 |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 1.62e-04 | 116 | 141 | 7 | MM14855 | |
| Pathway | REACTOME_INTRAFLAGELLAR_TRANSPORT | 1.66e-04 | 52 | 141 | 5 | MM15211 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | TUBA3D TUBA1C CD55 NEU3 TUBA8 TUBA4A GFPT1 TUBA1B TUBA1A MVD PMM2 | 1.74e-04 | 293 | 141 | 11 | MM15120 |
| Pathway | REACTOME_AUTOPHAGY | 1.87e-04 | 158 | 141 | 8 | M27935 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | TUBA3D TUBA1C LAMB1 TUBA3E ITGA2B TUBA8 TUBA4A TUBA3C GFRA3 TUBA1B RND1 TUBA1A SCN4A DNM3 CACNA1H PLXNA1 | 2.04e-04 | 575 | 141 | 16 | M29853 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 2.10e-04 | 204 | 141 | 9 | M4217 | |
| Pubmed | 4.72e-18 | 9 | 184 | 8 | 21167302 | ||
| Pubmed | 3.79e-14 | 19 | 184 | 8 | 15698476 | ||
| Pubmed | 3.79e-14 | 19 | 184 | 8 | 15691386 | ||
| Pubmed | 1.58e-13 | 22 | 184 | 8 | 28117675 | ||
| Pubmed | Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. | 5.61e-13 | 8 | 184 | 6 | 16148047 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 GTPBP6 MYCBP2 GRK5 OBSCN NSD1 LAMA5 SLCO4A1 CARD10 BTAF1 SH3BP4 ITPR2 VAC14 URB1 KMT2D IGF2R SETD5 TMEM259 PCNX1 CACNA1H RIC8A TNFAIP2 HERC2 PC DHX34 LTBP4 PLXNA1 HTT | 7.02e-12 | 1105 | 184 | 28 | 35748872 |
| Pubmed | 1.65e-11 | 22 | 184 | 7 | 15103018 | ||
| Pubmed | Systematic Analysis of the Functions of Lysine Acetylation in the Regulation of Tat Activity. | 1.65e-11 | 22 | 184 | 7 | 23826228 | |
| Pubmed | The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. | 1.82e-11 | 12 | 184 | 6 | 15331610 | |
| Pubmed | 2.34e-11 | 6 | 184 | 5 | 3785200 | ||
| Pubmed | The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. | 2.34e-11 | 6 | 184 | 5 | 7651436 | |
| Pubmed | 2.34e-11 | 6 | 184 | 5 | 16327313 | ||
| Pubmed | HIV-1 rev depolymerizes microtubules to form stable bilayered rings. | 3.36e-11 | 13 | 184 | 6 | 10908577 | |
| Pubmed | 5.86e-11 | 14 | 184 | 6 | 12486001 | ||
| Pubmed | 8.17e-11 | 7 | 184 | 5 | 11146551 | ||
| Pubmed | Interaction between metabotropic glutamate receptor 7 and alpha tubulin. | 4.86e-10 | 9 | 184 | 5 | 11953448 | |
| Pubmed | 7.58e-10 | 4 | 184 | 4 | 18400243 | ||
| Pubmed | NCAPD3 HBS1L ATR ARHGAP23 MYO19 OBSL1 SLCO4A1 BTAF1 TARS2 DICER1 TUBA4A SH3BP4 PARP4 ARHGEF1 TIMELESS TNFAIP2 HPS5 DHX34 | 1.33e-08 | 650 | 184 | 18 | 38777146 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TTF2 HBS1L IL18 GALK1 WASHC4 CASP14 DSC3 ARHGAP23 MYCBP2 SPTLC2 NPEPPS MYO19 PRDX2 DPF2 TUBA4A GFPT1 RLF USP5 URB1 PLAA ARHGEF1 RIC8A HERC2 DHX34 VARS1 PMM2 | 1.41e-08 | 1353 | 184 | 26 | 29467282 |
| Pubmed | 2.31e-08 | 17 | 184 | 5 | 17360745 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NCAPD3 ATR MYCBP2 SPTLC2 CD55 LAMA5 LAMB1 PRDX2 ITGA7 BGN ITPR2 USP5 SNX14 THBS1 VAC14 FBN1 IGF2R TMEM259 SEMA3B TIMELESS CKAP2 PLXNA1 HTT TANGO6 | 2.58e-08 | 1201 | 184 | 24 | 35696571 |
| Pubmed | 2.62e-08 | 7 | 184 | 4 | 36681692 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 11163133 | ||
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 11121746 | ||
| Pubmed | Tubulin and FtsZ structures: functional and therapeutic implications. | 1.46e-07 | 3 | 184 | 3 | 9722999 | |
| Pubmed | TTF2 NCAPD3 GALK1 MYCBP2 SPTLC2 NPEPPS MYO19 TUBA1C OBSL1 TUBA4A PARP4 MAGED4 RIC8A HERC2 VPS51 PC | 1.69e-07 | 606 | 184 | 16 | 36538041 | |
| Pubmed | CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer. | NPEPPS TUBA1C TUBA3E PRDX2 TUBA8 TUBA4A TUBA3C TUBA1B TUBA1A MYO3B ALB | 4.42e-07 | 288 | 184 | 11 | 31501420 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | TTF2 NCAPD3 SPTLC2 OBSL1 BTAF1 TARS2 GFPT1 USP5 VAC14 URB1 IGF2R PLAA LMBR1L TMEM259 ARHGEF1 RIC8A TIMELESS VPS51 VARS1 | 7.07e-07 | 942 | 184 | 19 | 31073040 |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 8.22e-07 | 139 | 184 | 8 | 25476789 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.43e-06 | 202 | 184 | 9 | 33005030 | |
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 2.19e-06 | 18 | 184 | 4 | 39040056 | |
| Pubmed | 2.88e-06 | 6 | 184 | 3 | 18613978 | ||
| Pubmed | 2.88e-06 | 6 | 184 | 3 | 12090300 | ||
| Pubmed | 2.88e-06 | 6 | 184 | 3 | 10840040 | ||
| Pubmed | 3.19e-06 | 285 | 184 | 10 | 32838362 | ||
| Pubmed | 3.47e-06 | 225 | 184 | 9 | 12168954 | ||
| Pubmed | SPTLC2 NPEPPS TUBA1C TUBA3E TUBA4A TUBA3C TUBA1B USP5 IGF2R PLAA TUBA1A GSTCD VARS1 MVD HTT TANGO6 PMM2 | 4.81e-06 | 878 | 184 | 17 | 37223481 | |
| Pubmed | Role of Caspases and Gasdermin A during HSV-1 Infection in Mice. | 5.02e-06 | 7 | 184 | 3 | 36146839 | |
| Pubmed | CD97 promotes spleen dendritic cell homeostasis through the mechanosensing of red blood cells. | 5.02e-06 | 7 | 184 | 3 | 35143305 | |
| Pubmed | 6.86e-06 | 50 | 184 | 5 | 23703321 | ||
| Pubmed | 8.00e-06 | 8 | 184 | 3 | 12417652 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYO19 PCLO OBSCN FAM227B GFPT1 ITPR2 PARP4 URB1 TRPM3 TUBA1A ATAD2B MYO3B CEP295 ALB ARHGAP20 | 9.77e-06 | 736 | 184 | 15 | 29676528 |
| Pubmed | 1.12e-05 | 94 | 184 | 6 | 36584595 | ||
| Pubmed | 1.20e-05 | 9 | 184 | 3 | 19103752 | ||
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 1.21e-05 | 27 | 184 | 4 | 31541017 | |
| Pubmed | 1.35e-05 | 146 | 184 | 7 | 27068509 | ||
| Pubmed | Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. | 1.70e-05 | 10 | 184 | 3 | 18590826 | |
| Pubmed | 1.70e-05 | 10 | 184 | 3 | 11784026 | ||
| Pubmed | MYT1L WASHC4 GTPBP6 MYCBP2 KDM5A OBSL1 LAMB1 WHAMM ZNF202 CHD9 GFPT1 TUBA1B THBS1 FBN1 DNM3 CIPC CKAP2 HERC2 PC VARS1 | 1.73e-05 | 1285 | 184 | 20 | 35914814 | |
| Pubmed | 1.83e-05 | 153 | 184 | 7 | 25037231 | ||
| Pubmed | 1.86e-05 | 212 | 184 | 8 | 23463506 | ||
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 1.86e-05 | 212 | 184 | 8 | 33853758 | |
| Pubmed | NCAPD3 GALK1 SPTLC2 NPEPPS MYO19 TARS2 DICER1 GFPT1 USP5 VAC14 IGF2R OCIAD1 ARHGEF1 MIPEP | 1.92e-05 | 686 | 184 | 14 | 28380382 | |
| Pubmed | ARHGAP23 TUBA3E TUBA8 TUBA4A TUBA3C TUBA1B THBS1 TUBA1A CACNA1H TIMELESS TNFAIP2 HERC2 | 2.06e-05 | 513 | 184 | 12 | 25798074 | |
| Pubmed | 2.33e-05 | 11 | 184 | 3 | 19269008 | ||
| Pubmed | Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle. | 2.33e-05 | 11 | 184 | 3 | 20405035 | |
| Pubmed | Mutational analysis of caspase genes in prostate carcinomas. | 2.33e-05 | 11 | 184 | 3 | 20402676 | |
| Pubmed | GALK1 NPEPPS TUBA1C LAMA5 LAMB1 FBXW2 ITGA2B TUBA1B IGF2R TUBA1A LTBP4 VARS1 PLXNA1 | 2.58e-05 | 613 | 184 | 13 | 22268729 | |
| Pubmed | SUMOylation regulates USP5-Cav3.2 calcium channel interactions. | 2.78e-05 | 2 | 184 | 2 | 31455361 | |
| Pubmed | The predictive value of maternal serum AFP to PAPP-A or b-hCG ratios in spontaneous preterm birth. | 2.78e-05 | 2 | 184 | 2 | 35620869 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 23929524 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 20178461 | ||
| Pubmed | A stress-induced, superoxide-mediated caspase-1 activation pathway causes plasma IL-18 upregulation. | 2.78e-05 | 2 | 184 | 2 | 15963782 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22354706 | ||
| Pubmed | Contribution of Langerhans cell-derived IL-18 to contact hypersensitivity. | 2.78e-05 | 2 | 184 | 2 | 11907086 | |
| Pubmed | Diverse calcium channel types are present in the human placental syncytiotrophoblast basal membrane. | 2.78e-05 | 2 | 184 | 2 | 16564089 | |
| Pubmed | Endogenous expression of TRPV5 and TRPV6 calcium channels in human leukemia K562 cells. | 2.78e-05 | 2 | 184 | 2 | 19295174 | |
| Pubmed | Human TRPV5 and TRPV6: key players in cadmium and zinc toxicity. | 2.78e-05 | 2 | 184 | 2 | 23968883 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 12390878 | ||
| Pubmed | IL-18 enhances thrombospondin-1 production in human gastric cancer via JNK pathway. | 2.78e-05 | 2 | 184 | 2 | 16650813 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22234890 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 9598326 | ||
| Pubmed | Differential expression of albumin and alpha-fetoprotein genes in fetal tissues of mouse and rat. | 2.78e-05 | 2 | 184 | 2 | 6199242 | |
| Pubmed | TRPV5 and TRPV6 are expressed in placenta and bone tissues during pregnancy in mice. | 2.78e-05 | 2 | 184 | 2 | 30916584 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 27130589 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 6192711 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 18523249 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 7899085 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 37144518 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 16565876 | ||
| Pubmed | Interleukin-18 protein level is upregulated in adipose tissue of obese mice. | 2.78e-05 | 2 | 184 | 2 | 19039317 | |
| Pubmed | Acetylated α-tubulin is reduced in individuals with poor sperm motility. | 2.78e-05 | 2 | 184 | 2 | 24268707 | |
| Pubmed | Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control. | 2.78e-05 | 2 | 184 | 2 | 8682297 | |
| Pubmed | Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. | 2.78e-05 | 2 | 184 | 2 | 11342578 | |
| Pubmed | The rate of molecular evolution of alpha-fetoprotein approaches that of pseudogenes. | 2.78e-05 | 2 | 184 | 2 | 2452956 | |
| Pubmed | Age-dependent alterations in Ca2+ homeostasis: role of TRPV5 and TRPV6. | 2.78e-05 | 2 | 184 | 2 | 16705151 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 17984289 | ||
| Pubmed | Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. | 2.78e-05 | 2 | 184 | 2 | 10353249 | |
| Pubmed | Suppression of Ca2+ signals by EGR4 controls Th1 differentiation and anti-cancer immunity in vivo. | 2.78e-05 | 2 | 184 | 2 | 32212315 | |
| Pubmed | Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes. | 2.78e-05 | 2 | 184 | 2 | 6206499 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 6206473 | ||
| Pubmed | Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma. | 2.78e-05 | 2 | 184 | 2 | 16428475 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 20405023 | ||
| Pubmed | Mapping of the hooded, Gc protein, and albumin gene loci in linkage group VI of the laboratory rat. | 2.78e-05 | 2 | 184 | 2 | 3242495 | |
| Pubmed | A single amino acid mutation results in a rapid inactivation of epithelial calcium channels. | 2.78e-05 | 2 | 184 | 2 | 11846401 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 23891063 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 12393844 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 24761864 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 31138428 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 24615654 | ||
| Interaction | TCP11L2 interactions | 4.39e-10 | 21 | 181 | 7 | int:TCP11L2 | |
| Interaction | THBS3 interactions | 2.08e-08 | 74 | 181 | 9 | int:THBS3 | |
| Interaction | GPR182 interactions | NCAPD3 WASHC4 ATR MYO19 BTAF1 TARS2 TUBA3C FANCG SNX14 URB1 TUBA1A TMEM259 DNM3 TIMELESS TNFAIP2 NOCT VPS51 HTT | 1.60e-07 | 455 | 181 | 18 | int:GPR182 |
| Interaction | GRM7 interactions | 5.81e-07 | 19 | 181 | 5 | int:GRM7 | |
| Interaction | TMEM25 interactions | 3.47e-06 | 134 | 181 | 9 | int:TMEM25 | |
| Interaction | LY86 interactions | TUBA1C CD55 LAMA5 LAMB1 NEU3 ITGA7 THBS1 TRMT44 TUBA1A SEMA3B PLXNA1 | 4.44e-06 | 217 | 181 | 11 | int:LY86 |
| Interaction | F12 interactions | 5.94e-06 | 77 | 181 | 7 | int:F12 | |
| Interaction | EFNA4 interactions | NCAPD3 ATR BTAF1 ITGA2B URB1 PLAA TUBA1A DNM3 TIMELESS ALB VPS51 | 1.11e-05 | 239 | 181 | 11 | int:EFNA4 |
| Interaction | CD48 interactions | 2.49e-05 | 39 | 181 | 5 | int:CD48 | |
| Interaction | SNX21 interactions | 3.06e-05 | 67 | 181 | 6 | int:SNX21 | |
| Interaction | DNAJA2 interactions | TTF2 HBS1L TUBA1C OBSL1 ITGA2B TARS2 TUBA4A TUBA1B LMBR1L TUBA1A NOCT HPS5 DHX34 VARS1 HTT TANGO6 | 3.24e-05 | 542 | 181 | 16 | int:DNAJA2 |
| Interaction | ADAM7 interactions | 4.04e-05 | 43 | 181 | 5 | int:ADAM7 | |
| Interaction | NPTN interactions | ATR TUBA1C BTAF1 TUBA4A FANCG VAC14 LMBR1L TUBA1A TNFAIP2 VPS51 HTT | 4.48e-05 | 278 | 181 | 11 | int:NPTN |
| Interaction | SLURP1 interactions | 4.83e-05 | 144 | 181 | 8 | int:SLURP1 | |
| Interaction | GPR17 interactions | WASHC4 ATR BTAF1 ITPR2 FANCG VAC14 URB1 PLAA TIMELESS TNFAIP2 HTT | 5.26e-05 | 283 | 181 | 11 | int:GPR17 |
| Interaction | EDN3 interactions | 5.46e-05 | 108 | 181 | 7 | int:EDN3 | |
| Interaction | PRG2 interactions | ADAMTS2 LAMA5 ITGA7 DICER1 TUBA4A THBS1 TUBA1A SEMA3B PAPPA LTBP4 PLXNA1 | 5.60e-05 | 285 | 181 | 11 | int:PRG2 |
| Interaction | KLK5 interactions | 5.79e-05 | 109 | 181 | 7 | int:KLK5 | |
| Interaction | CDRT15P3 interactions | 5.81e-05 | 24 | 181 | 4 | int:CDRT15P3 | |
| Interaction | CDK20 interactions | 7.69e-05 | 114 | 181 | 7 | int:CDK20 | |
| Interaction | SUSD4 interactions | 8.44e-05 | 50 | 181 | 5 | int:SUSD4 | |
| Interaction | FAXC interactions | 9.57e-05 | 118 | 181 | 7 | int:FAXC | |
| Interaction | LRRC31 interactions | 1.02e-04 | 205 | 181 | 9 | int:LRRC31 | |
| Interaction | HCST interactions | 1.02e-04 | 205 | 181 | 9 | int:HCST | |
| Interaction | MFAP5 interactions | 1.02e-04 | 52 | 181 | 5 | int:MFAP5 | |
| Interaction | LTA interactions | 1.09e-04 | 28 | 181 | 4 | int:LTA | |
| Interaction | CCT3 interactions | CFAP300 MYCBP2 TUBA1C OBSL1 TUBA3E PRDX2 TUBA4A TUBA3C SH3BP4 TUBA1B VAC14 JMJD7 TUBA1A PC VARS1 HTT | 1.16e-04 | 604 | 181 | 16 | int:CCT3 |
| Interaction | TOP3B interactions | VWA5B2 GTPBP6 MYCBP2 GRK5 OBSCN NSD1 LAMA5 SLCO4A1 CARD10 BTAF1 SH3BP4 ITPR2 VAC14 URB1 KMT2D IGF2R SETD5 TMEM259 PCNX1 CACNA1H RIC8A TNFAIP2 HERC2 PC DHX34 LTBP4 PLXNA1 HTT | 1.25e-04 | 1470 | 181 | 28 | int:TOP3B |
| Interaction | TXNDC9 interactions | 1.31e-04 | 124 | 181 | 7 | int:TXNDC9 | |
| Interaction | IL12RB1 interactions | 1.34e-04 | 87 | 181 | 6 | int:IL12RB1 | |
| Interaction | CFC1 interactions | 1.44e-04 | 126 | 181 | 7 | int:CFC1 | |
| Interaction | TUBA1B interactions | SFMBT1 KDM5A MYO19 TUBA1C OBSL1 TUBA3E DPF2 ITGAD TUBA4A TUBA1B RND1 TUBA1A VARS1 HTT | 1.70e-04 | 498 | 181 | 14 | int:TUBA1B |
| Interaction | LYPD1 interactions | 1.72e-04 | 58 | 181 | 5 | int:LYPD1 | |
| Interaction | CLEC16A interactions | TTF2 NCAPD3 GALK1 MYCBP2 SPTLC2 NPEPPS MYO19 TUBA1C OBSL1 TUBA4A PARP4 MAGED4 RIC8A HERC2 VPS51 PC | 1.84e-04 | 629 | 181 | 16 | int:CLEC16A |
| Interaction | MGARP interactions | 1.86e-04 | 222 | 181 | 9 | int:MGARP | |
| Interaction | NSUN5P1 interactions | 1.87e-04 | 59 | 181 | 5 | int:NSUN5P1 | |
| Interaction | BSG interactions | ATR TUBA3D TUBA1C TUBA3E BTAF1 TUBA8 TUBA4A TUBA3C TUBA1B VAC14 RND1 LMBR1L TUBA1A DNM3 TNFAIP2 VPS51 | 1.90e-04 | 631 | 181 | 16 | int:BSG |
| Interaction | FAM174A interactions | 1.98e-04 | 224 | 181 | 9 | int:FAM174A | |
| Interaction | C1QB interactions | 2.04e-04 | 94 | 181 | 6 | int:C1QB | |
| Interaction | FOXRED2 interactions | 2.29e-04 | 96 | 181 | 6 | int:FOXRED2 | |
| Interaction | TSHR interactions | 2.29e-04 | 96 | 181 | 6 | int:TSHR | |
| Interaction | ISLR interactions | 2.53e-04 | 138 | 181 | 7 | int:ISLR | |
| Interaction | ANTXR1 interactions | 2.53e-04 | 138 | 181 | 7 | int:ANTXR1 | |
| Interaction | THTPA interactions | 2.55e-04 | 63 | 181 | 5 | int:THTPA | |
| Interaction | PHF21A interactions | SFMBT1 MYCBP2 GIT2 SOX8 CLOCK RLF KMT2D VPS51 PC TANGO6 NPAT | 2.84e-04 | 343 | 181 | 11 | int:PHF21A |
| Interaction | OIT3 interactions | 2.95e-04 | 65 | 181 | 5 | int:OIT3 | |
| Interaction | KLK11 interactions | 2.96e-04 | 36 | 181 | 4 | int:KLK11 | |
| Interaction | CAPSL interactions | 2.99e-04 | 15 | 181 | 3 | int:CAPSL | |
| Interaction | SKAP1 interactions | 3.19e-04 | 102 | 181 | 6 | int:SKAP1 | |
| Cytoband | 12q13.12 | 4.42e-07 | 38 | 184 | 5 | 12q13.12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 3.32e-04 | 423 | 184 | 8 | chr12q13 | |
| Cytoband | 12p11 | 5.65e-04 | 9 | 184 | 2 | 12p11 | |
| GeneFamily | Tubulins | 4.81e-12 | 26 | 122 | 8 | 778 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 5.61e-06 | 18 | 122 | 4 | 1160 | |
| GeneFamily | Caspases|Caspase recruitment domain containing | 8.16e-05 | 13 | 122 | 3 | 468 | |
| GeneFamily | PHD finger proteins | 3.58e-04 | 90 | 122 | 5 | 88 | |
| GeneFamily | Transient receptor potential cation channels | 8.68e-04 | 28 | 122 | 3 | 249 | |
| GeneFamily | Desmosomal cadherins | 9.28e-04 | 7 | 122 | 2 | 1188 | |
| GeneFamily | Laminin subunits | 2.85e-03 | 12 | 122 | 2 | 626 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | HK3 SH2D3A OBSCN OBSL1 LAMB1 NEU3 CARD10 ITGA2B NPEPL1 TUBA4A BGN JMJD7 TMEM259 CACNA1H TNFAIP2 PC DHX34 LTBP4 VARS1 PLXNA1 NPAT | 1.53e-06 | 909 | 182 | 21 | M41018 |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP | 1.16e-05 | 200 | 182 | 9 | M3774 | |
| Coexpression | GSE17721_0.5H_VS_4H_POLYIC_BMDC_DN | 1.16e-05 | 200 | 182 | 9 | M4091 | |
| Coexpression | NABA_CORE_MATRISOME | VWA5B2 COL16A1 ZPLD1 LAMA5 LAMB1 BGN THBS1 FBN1 EGFLAM LTBP4 | 2.06e-05 | 270 | 182 | 10 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | VWA5B2 COL16A1 ZPLD1 LAMA5 LAMB1 BGN THBS1 FBN1 EGFLAM LTBP4 | 2.41e-05 | 275 | 182 | 10 | M5884 |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 5.22e-05 | 11 | 182 | 3 | M566 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.96e-05 | 191 | 182 | 8 | MM17059 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 6.65e-05 | 194 | 182 | 8 | M39122 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 7.14e-05 | 196 | 182 | 8 | M3008 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 7.16e-05 | 313 | 182 | 10 | M40228 | |
| Coexpression | MODY_HIPPOCAMPUS_NEONATAL | 7.86e-05 | 33 | 182 | 4 | M7409 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_UP | 8.22e-05 | 200 | 182 | 8 | M8049 | |
| Coexpression | GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN | 8.22e-05 | 200 | 182 | 8 | M3508 | |
| Coexpression | GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN | 8.22e-05 | 200 | 182 | 8 | M4962 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP | 8.22e-05 | 200 | 182 | 8 | M6262 | |
| Coexpression | GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_UP | 8.22e-05 | 200 | 182 | 8 | M4115 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_NEUTROPHIL_CELL | 9.69e-05 | 66 | 182 | 5 | M45733 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SFMBT1 WASHC4 ATR MYCBP2 KDM5A NPEPPS GRK5 CHD9 BTAF1 CLOCK DICER1 RLF IGF2R ATAD2B MITF PMM2 NPAT | 1.05e-04 | 856 | 182 | 17 | M4500 |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | IL18 ATR MYO19 CD55 NEU3 TUBA3E GFPT1 ITPR2 NOL4L URB1 IGF2R TUBA1A EGR1 ATAD2B MIPEP PCNX1 VARS1 HTT | 1.06e-04 | 942 | 182 | 18 | M8144 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | ADAMTS2 GRK5 CD55 LAMB1 MUC16 BGN FBN1 IGF2R EGR1 EGFLAM ARHGAP20 LTBP4 | 3.31e-05 | 336 | 181 | 12 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | ADAMTS2 GRK5 CD55 MUC16 BGN FBN1 EGR1 CACNA1H EGFLAM ARHGAP20 LTBP4 | 7.49e-05 | 310 | 181 | 11 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | GRK5 CD55 MUC16 BGN ITPR2 THBS1 CFAP54 FBN1 EGR1 ARHGAP20 LTBP4 CDH3 | 8.78e-05 | 372 | 181 | 12 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 8.78e-05 | 165 | 181 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | ADAMTS2 GRK5 OBSL1 CD55 MUC16 BGN THBS1 FBN1 EGFLAM ARHGAP20 LTBP4 CDH3 | 9.01e-05 | 373 | 181 | 12 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#2_top-relative-expression-ranked_500 | 1.21e-04 | 129 | 181 | 7 | gudmap_developingGonad_e16.5_testes_500_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.27e-04 | 130 | 181 | 7 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 1.29e-04 | 91 | 181 | 6 | GSM777059_100 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL16A1 ADAMTS2 G0S2 LAMB1 ITGA7 BGN THBS1 FBN1 EGFLAM TNFAIP2 | 7.57e-09 | 191 | 184 | 10 | b7a57691a4742070cee640e285c1f4d0da95baf1 |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL16A1 ADAMTS2 G0S2 LAMB1 BGN THBS1 FBN1 PAPPA ARHGAP20 LTBP4 | 7.96e-09 | 192 | 184 | 10 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL16A1 ADAMTS2 G0S2 LAMB1 BGN THBS1 FBN1 PAPPA ARHGAP20 LTBP4 | 7.96e-09 | 192 | 184 | 10 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | COL16A1 ADAMTS2 G0S2 LAMB1 BGN THBS1 FBN1 PAPPA ARHGAP20 LTBP4 | 7.96e-09 | 192 | 184 | 10 | ac1477433704573f95111eee6263b93668d2845e |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-08 | 159 | 184 | 9 | 7ed659163f45e0c4df4782997c0786900c8186c8 | |
| ToppCell | Control-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 9.34e-08 | 188 | 184 | 9 | 47126c371a242c937499fd278a74a882df8f759c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.12e-07 | 192 | 184 | 9 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | Control-Myeloid-cMonocyte|Control / Disease state, Lineage and Cell class | 1.12e-07 | 192 | 184 | 9 | ad04c9c4bdebf94615cee1904ca48197e62c923b | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.22e-07 | 194 | 184 | 9 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-07 | 194 | 184 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Control-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 1.22e-07 | 194 | 184 | 9 | f852f5258617a66a4fbd56d64c7b47272e7b8b60 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.45e-07 | 198 | 184 | 9 | 5374b0e98d669f36a0571d3c006c7bd5e3c8e87f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-07 | 199 | 184 | 9 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | E16.5-Mesenchymal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-07 | 199 | 184 | 9 | ebd9ca151434f5ca27a82d4f1815a1ea500c1989 | |
| ToppCell | Biopsy_IPF-Immune-Monocytes|Biopsy_IPF / Sample group, Lineage and Cell type | 1.58e-07 | 200 | 184 | 9 | 80b2b7eecc5dce9d22f9c80562e4aea83bbf0f50 | |
| ToppCell | Pericytes-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 8.98e-07 | 181 | 184 | 8 | ff445a8e56522e57e27405184d123cf905caf8cc | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.36e-07 | 182 | 184 | 8 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-06 | 184 | 184 | 8 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 1.02e-06 | 184 | 184 | 8 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue | 1.10e-06 | 186 | 184 | 8 | a16ecf70271894a842925f232009e2623d16947e | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.10e-06 | 186 | 184 | 8 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-06 | 188 | 184 | 8 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.19e-06 | 188 | 184 | 8 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.24e-06 | 189 | 184 | 8 | 2aebea7a6c2f83112d7c504b742f2c04b92e459a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-06 | 189 | 184 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_monocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.29e-06 | 190 | 184 | 8 | 00ef6ec71353e42260c0d807d7da65b63154c288 | |
| ToppCell | IPF-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 1.29e-06 | 190 | 184 | 8 | ffa890138394f579fee53fcfac6c121bf86adc26 | |
| ToppCell | IPF-Myeloid-cMonocyte|IPF / Disease state, Lineage and Cell class | 1.29e-06 | 190 | 184 | 8 | a099f51f2b7618b6712af38eedd5ee64d8663a4a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.29e-06 | 190 | 184 | 8 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.29e-06 | 190 | 184 | 8 | 18c020ca9a23399214133ec255ab870e0060f2e1 | |
| ToppCell | droplet-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-06 | 192 | 184 | 8 | 086b47f87283cd41139cd56686011f8b5821b0da | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-06 | 192 | 184 | 8 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 192 | 184 | 8 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 192 | 184 | 8 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-06 | 192 | 184 | 8 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-06 | 192 | 184 | 8 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.45e-06 | 193 | 184 | 8 | 5f732598cdb6f3bd519f044a9cc553bd2e8b1052 | |
| ToppCell | PND07-28-samps-Mesenchymal|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.51e-06 | 194 | 184 | 8 | 68bcc1fe8dc8d5f23a12154fc9b41362fdef0b1d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-06 | 195 | 184 | 8 | cbe518b465b4ef32797ae6b608219207c08493df | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.57e-06 | 195 | 184 | 8 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-06 | 195 | 184 | 8 | 0ec1b572bbb92b6da3440139366a4c1743b1ad92 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.57e-06 | 195 | 184 | 8 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-06 | 195 | 184 | 8 | 136b06b0931a69b1241101f68c01c44c70365fd9 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-06 | 196 | 184 | 8 | 614a07334707eafe238d5cb7b080a3ca796a1920 | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-06 | 196 | 184 | 8 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | PND07-Mesenchymal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.63e-06 | 196 | 184 | 8 | 0050c7134473fbfd7b9f0ae8d6d337713e60b57d | |
| ToppCell | 368C|World / Donor, Lineage, Cell class and subclass (all cells) | 1.70e-06 | 197 | 184 | 8 | f41211923938e5d7bfe6bf24f604ab386f17ef10 | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-06 | 197 | 184 | 8 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.70e-06 | 197 | 184 | 8 | bb0d814d88a14199eb8ab2b3bd67511b19e3ab5d | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.70e-06 | 197 | 184 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.70e-06 | 197 | 184 | 8 | a1d42d0177630e08f36a96a6272f796244c1a319 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.70e-06 | 197 | 184 | 8 | 4a6eff66a17c5e89bda61d887b736f5c62b93bd7 | |
| ToppCell | PBMC-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 1.76e-06 | 198 | 184 | 8 | fb873b7636bb1c7b119dd5b23d7a20f518e6c6da | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.76e-06 | 198 | 184 | 8 | 0993d6895c0e4f360998ce35abea4ec3dd13e048 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.76e-06 | 198 | 184 | 8 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.83e-06 | 199 | 184 | 8 | 667b8b47a5b388506e3177b46747267fad8024f6 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.90e-06 | 200 | 184 | 8 | 38190e4b32f7469df1da7d130bca6d7b12a3dd06 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.90e-06 | 200 | 184 | 8 | d769723f8fcb37d9b86589e0c41c1d7f16393cfe | |
| ToppCell | Biopsy_Control_(H.)-Immune-Monocytes|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.90e-06 | 200 | 184 | 8 | c58a5dc0a0d74a21ca15ee8b7a0197de32afa045 | |
| ToppCell | (40)_Monocyte|World / shred on Cell_type and subtype | 2.36e-06 | 206 | 184 | 8 | d78a70f951265ef6df8f64404107be4f53e75d28 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.75e-06 | 165 | 184 | 7 | 1dcd6b8aa192baeaa1f7bb334843edab6049b96f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.23e-06 | 167 | 184 | 7 | b0eb7a40491dd2432f5282f578ce569df86d21a7 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-06 | 168 | 184 | 7 | 4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 169 | 184 | 7 | 454b92b9b67299a64278c010db033ca5b9d217a0 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.73e-06 | 169 | 184 | 7 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-06 | 171 | 184 | 7 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.55e-06 | 172 | 184 | 7 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-06 | 174 | 184 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.45e-06 | 175 | 184 | 7 | aa168aeb9ad71aa6c0c28a0657c9eb92a0b28183 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.45e-06 | 175 | 184 | 7 | c031da47ca63d1133e13530cbf779df9435e22cb | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.10e-06 | 177 | 184 | 7 | cdad5a2f672a7f07c05669bfcaf1ec74defd3de7 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.10e-06 | 177 | 184 | 7 | 345cebc19f93970a9a46be139208b300081f5493 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.10e-06 | 177 | 184 | 7 | 991ae76bb615392d84aeb89886148fa42c1c649c | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-05 | 180 | 184 | 7 | 66c7b02d85e32ba3e7530d0c4aff17e7525ccdd8 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-05 | 180 | 184 | 7 | 41896546cd1cc458e08c0d4e19aa4860e5d4fcd6 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 1.02e-05 | 180 | 184 | 7 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.02e-05 | 180 | 184 | 7 | 97241f62ee133dcb0d4855ffda5dd1349de9f7b2 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.13e-05 | 183 | 184 | 7 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-05 | 183 | 184 | 7 | ebe369dc80c4fbf8f4dbe947147f8c47507ffb60 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 185 | 184 | 7 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 185 | 184 | 7 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.26e-05 | 186 | 184 | 7 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell|TCGA-Uvea / Sample_Type by Project: Shred V9 | 1.26e-05 | 186 | 184 | 7 | e8580a2093eb7e50aad55ec7fada850d2fed8ae1 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.30e-05 | 187 | 184 | 7 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | P15-Mesenchymal|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.35e-05 | 188 | 184 | 7 | f1ba0b661621a65c91432e62ba73531bdf18e7c1 | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 1.39e-05 | 189 | 184 | 7 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 189 | 184 | 7 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 189 | 184 | 7 | 62e46d59d3b89d4566b595c704d8b02f1ea9060b | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 189 | 184 | 7 | 37ce47abd6f96df04d35a4a6189d007bef5ccc94 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 189 | 184 | 7 | b55324cb365a827d071952709bbf0e8ef8c313de | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.39e-05 | 189 | 184 | 7 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 1.44e-05 | 190 | 184 | 7 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-05 | 190 | 184 | 7 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 190 | 184 | 7 | 3720e64129f3f3268b1dc14031a76f41c38241c2 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 190 | 184 | 7 | 73a50426f972f08f9bb525ad5c0b774187ab5d6a | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 190 | 184 | 7 | b55cf1fb586b724295b7b038483249847bb344fc | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-05 | 191 | 184 | 7 | 44a9a6768084dafc641ad455b65862bfd4cc0cb9 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-05 | 191 | 184 | 7 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-05 | 191 | 184 | 7 | abdd93b2313e635f75a750d051a6a01ddc4e2df9 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-05 | 192 | 184 | 7 | efbd52b3d2b6d3fb9ed6bc3f36aca9f4f1fcbc49 | |
| Computational | Adhesion molecules. | 4.65e-06 | 141 | 123 | 10 | MODULE_122 | |
| Drug | Epothilone D | 2.20e-10 | 12 | 183 | 6 | DB01873 | |
| Drug | Epothilone B | 2.20e-10 | 12 | 183 | 6 | DB03010 | |
| Drug | AC1L2P05 | 2.24e-08 | 23 | 183 | 6 | CID000125688 | |
| Drug | CA1P | 3.87e-08 | 25 | 183 | 6 | CID006918545 | |
| Drug | evodiamine | 1.29e-07 | 73 | 183 | 8 | CID000151289 | |
| Drug | AC7700 | 1.55e-07 | 31 | 183 | 6 | CID006918404 | |
| Drug | trypanothione disulfide | IL18 ADAMTS2 LAMA5 LAMB1 ITGA2B ITGA7 ITGAD ITGAX THBS1 CKAP2 | 2.05e-07 | 140 | 183 | 10 | CID000115098 |
| Drug | DTAF | 4.69e-07 | 37 | 183 | 6 | CID000123934 | |
| Drug | albendazole | 4.69e-07 | 37 | 183 | 6 | CID000002082 | |
| Drug | bromocolchicine | 5.82e-07 | 21 | 183 | 5 | CID000161518 | |
| Drug | colchifoline | 5.82e-07 | 21 | 183 | 5 | CID000100132 | |
| Drug | Ustiloxin A | 5.82e-07 | 21 | 183 | 5 | CID000164454 | |
| Drug | SRI-3072 | 5.82e-07 | 21 | 183 | 5 | CID000493469 | |
| Drug | 3,4,5-trimethoxyacetophenone | 7.49e-07 | 22 | 183 | 5 | CID000014345 | |
| Drug | AC1L1GIQ | 7.49e-07 | 22 | 183 | 5 | CID000003700 | |
| Drug | 2,4-dichlorobenzyl thiocyanate | 7.49e-07 | 22 | 183 | 5 | CID000098538 | |
| Drug | SureCN13401588 | 7.49e-07 | 22 | 183 | 5 | CID009897422 | |
| Drug | N-methyldemecolcine | 7.49e-07 | 22 | 183 | 5 | CID000023759 | |
| Drug | NSC-339672 | 7.49e-07 | 22 | 183 | 5 | CID000433930 | |
| Drug | AC1L8GZ1 | 7.60e-07 | 40 | 183 | 6 | CID000381235 | |
| Drug | amoebal | 8.84e-07 | 41 | 183 | 6 | CID000001985 | |
| Drug | 3,4,5-trimethoxybenzaldehyde | 9.50e-07 | 23 | 183 | 5 | CID000006858 | |
| Drug | 2,3,4-tabp | 9.50e-07 | 23 | 183 | 5 | CID000125548 | |
| Drug | NSC-373301 | 9.50e-07 | 23 | 183 | 5 | CID000341375 | |
| Drug | NSC355636 | 9.50e-07 | 23 | 183 | 5 | CID000100176 | |
| Drug | IKP104 | 9.50e-07 | 23 | 183 | 5 | CID000130739 | |
| Drug | fluorescein-colchicine | 9.50e-07 | 23 | 183 | 5 | CID003035871 | |
| Drug | 3-demethylthiocolchicine | 9.50e-07 | 23 | 183 | 5 | CID000084076 | |
| Drug | 2,3,4-TCB | 9.50e-07 | 23 | 183 | 5 | CID000129239 | |
| Drug | N-acetylcolchinol | 9.50e-07 | 23 | 183 | 5 | CID000097865 | |
| Drug | parbendazole | 1.19e-06 | 24 | 183 | 5 | CID000026596 | |
| Drug | tropolone methyl ether | 1.19e-06 | 24 | 183 | 5 | CID000016546 | |
| Drug | 7-epi-cephalomannine | 1.19e-06 | 24 | 183 | 5 | CID000330401 | |
| Drug | NABV | 1.19e-06 | 24 | 183 | 5 | CID000175959 | |
| Drug | AC1L4TG7 | 1.19e-06 | 24 | 183 | 5 | CID000163705 | |
| Drug | moscatilin | 1.19e-06 | 24 | 183 | 5 | CID000176096 | |
| Drug | NSC-36768 | 1.19e-06 | 24 | 183 | 5 | CID000165441 | |
| Drug | deacetamidocolchicine | 1.19e-06 | 24 | 183 | 5 | CID000014995 | |
| Drug | colchicide | 1.19e-06 | 24 | 183 | 5 | CID000120712 | |
| Drug | mpMap | 1.48e-06 | 25 | 183 | 5 | CID000100806 | |
| Drug | AC1Q6P06 | 1.48e-06 | 25 | 183 | 5 | CID000160263 | |
| Drug | allocolchicine | 1.48e-06 | 25 | 183 | 5 | CID000196989 | |
| Drug | 1069C85 | 1.48e-06 | 25 | 183 | 5 | CID006918099 | |
| Drug | 55623-37-5 | 1.48e-06 | 25 | 183 | 5 | CID006438440 | |
| Drug | MDL 27048 | 1.48e-06 | 25 | 183 | 5 | CID006439188 | |
| Drug | NBD-colcemid | 1.48e-06 | 25 | 183 | 5 | CID000130594 | |
| Drug | 2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone | 1.48e-06 | 25 | 183 | 5 | CID000043264 | |
| Drug | peloruside A | 1.48e-06 | 25 | 183 | 5 | CID006918506 | |
| Drug | NSC142227 | 1.48e-06 | 25 | 183 | 5 | CID000073427 | |
| Drug | NSC527981 | 1.82e-06 | 26 | 183 | 5 | CID000352796 | |
| Drug | NSC332029 | 1.82e-06 | 26 | 183 | 5 | CID000100073 | |
| Drug | indibulin | 1.82e-06 | 26 | 183 | 5 | CID000002929 | |
| Drug | pironetin | 1.82e-06 | 26 | 183 | 5 | CID006438891 | |
| Drug | isaxonine | 1.82e-06 | 26 | 183 | 5 | CID000071169 | |
| Drug | 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE | 2.03e-06 | 4 | 183 | 3 | DB07574 | |
| Drug | AC1L1J4H | 2.22e-06 | 27 | 183 | 5 | CID000004862 | |
| Drug | dinitroanilines | 2.22e-06 | 27 | 183 | 5 | CID000136400 | |
| Drug | NSC292222 | 2.22e-06 | 27 | 183 | 5 | CID000099957 | |
| Drug | NSC D-669356 | 2.22e-06 | 27 | 183 | 5 | CID000178028 | |
| Drug | NSC 370147 | 2.69e-06 | 28 | 183 | 5 | CID000182762 | |
| Drug | NSC72302 | 2.69e-06 | 28 | 183 | 5 | CID000118078 | |
| Drug | Z)-combretastatin A-4 | 2.94e-06 | 50 | 183 | 6 | CID000072686 | |
| Drug | vinblastine | CDH26 TUBA1C TUBA3E TUBA8 TUBA4A TUBA1B TUBA1A AFP GSTCD PLXNA1 | 3.20e-06 | 189 | 183 | 10 | CID000013342 |
| Drug | bp U | 3.22e-06 | 29 | 183 | 5 | CID000368697 | |
| Drug | oxibendazole | 3.22e-06 | 29 | 183 | 5 | CID000004622 | |
| Drug | Aids106696 | 3.22e-06 | 29 | 183 | 5 | CID006475933 | |
| Drug | ddGDP | 3.22e-06 | 29 | 183 | 5 | CID000134739 | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.51e-06 | 191 | 183 | 10 | 7339_UP | |
| Drug | AC1NBBHE | 3.84e-06 | 30 | 183 | 5 | CID004490620 | |
| Drug | eleutherobin | 3.84e-06 | 30 | 183 | 5 | CID006918335 | |
| Drug | azatoxin | 3.84e-06 | 30 | 183 | 5 | CID000125383 | |
| Drug | NSC617668 | 3.84e-06 | 30 | 183 | 5 | CID000357989 | |
| Drug | citostal | 3.84e-06 | 30 | 183 | 5 | CID000018991 | |
| Drug | thiocolchicine | 3.84e-06 | 30 | 183 | 5 | CID000017648 | |
| Drug | Rgd Peptide | TBXAS1 PSG7 CD55 LAMA5 LAMB1 ITGA2B ITGA7 ITGAD ITGAX THBS1 FBN1 | 3.95e-06 | 239 | 183 | 11 | CID000104802 |
| Drug | B-Ms | 3.98e-06 | 114 | 183 | 8 | CID000445091 | |
| Drug | procaine | 4.24e-06 | 153 | 183 | 9 | CID000004914 | |
| Drug | NSC609395 | 4.55e-06 | 31 | 183 | 5 | CID005488798 | |
| Drug | amiprophosmethyl | 4.55e-06 | 31 | 183 | 5 | CID000100524 | |
| Drug | 3,4-dimethylhexane-2,5-dione | 4.55e-06 | 31 | 183 | 5 | CID000032851 | |
| Drug | tropone | 4.55e-06 | 31 | 183 | 5 | CID000010881 | |
| Drug | AC1L3V8I | 4.55e-06 | 31 | 183 | 5 | CID000122777 | |
| Drug | NSC332598 | 4.55e-06 | 31 | 183 | 5 | CID000615942 | |
| Drug | N,N'-ethylenebis(iodoacetamide | 4.55e-06 | 31 | 183 | 5 | CID000023678 | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 4.84e-06 | 198 | 183 | 10 | 6106_UP | |
| Drug | AC1L1G95 | 5.36e-06 | 32 | 183 | 5 | CID000003583 | |
| Drug | NSC153858 | 5.36e-06 | 32 | 183 | 5 | CID000547450 | |
| Drug | E2-3,4-Q | 5.36e-06 | 32 | 183 | 5 | CID000067402 | |
| Drug | 2-demethylcolchicine | 5.36e-06 | 32 | 183 | 5 | CID000023757 | |
| Drug | AC1L8WWP | 5.78e-06 | 56 | 183 | 6 | CID000388944 | |
| Drug | mebendazole | 6.28e-06 | 33 | 183 | 5 | CID000004030 | |
| Drug | CA4P | 6.28e-06 | 33 | 183 | 5 | CID000370232 | |
| Drug | taltobulin | 6.28e-06 | 33 | 183 | 5 | CID006918637 | |
| Drug | triethyllead | 7.31e-06 | 34 | 183 | 5 | CID006328106 | |
| Drug | NSC376450 | 7.31e-06 | 34 | 183 | 5 | CID000005605 | |
| Drug | 2-phenyl-4-quinolone | 7.31e-06 | 34 | 183 | 5 | CID000161091 | |
| Drug | discodermolide | 8.48e-06 | 35 | 183 | 5 | CID000643668 | |
| Drug | rotigotine patch | 1.02e-05 | 93 | 183 | 7 | CID003619466 | |
| Drug | AC1O5Y0F | 1.12e-05 | 37 | 183 | 5 | CID006442852 | |
| Drug | baccatin III | 1.12e-05 | 37 | 183 | 5 | CID000065366 | |
| Disease | microlissencephaly (implicated_via_orthology) | 1.36e-18 | 8 | 176 | 8 | DOID:0112234 (implicated_via_orthology) | |
| Disease | lissencephaly 3 (implicated_via_orthology) | 1.36e-18 | 8 | 176 | 8 | DOID:0112232 (implicated_via_orthology) | |
| Disease | polymicrogyria (implicated_via_orthology) | 1.36e-18 | 8 | 176 | 8 | DOID:0080918 (implicated_via_orthology) | |
| Disease | lissencephaly (implicated_via_orthology) | 2.75e-12 | 27 | 176 | 8 | DOID:0050453 (implicated_via_orthology) | |
| Disease | platelet crit | HBS1L NPEPPS LAMA5 ITGA2B TARS2 ITGAD ITGAX PTGR3 SH3BP4 ITPR2 THBS1 NOL4L TADA2B MITF CDH3 NPAT | 1.98e-04 | 952 | 176 | 16 | EFO_0007985 |
| Disease | suntan, skin pigmentation | 2.11e-04 | 4 | 176 | 2 | EFO_0003784, EFO_0004279 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 2.43e-04 | 93 | 176 | 5 | DOID:3525 (biomarker_via_orthology) | |
| Disease | Malformation of cortical development | 5.22e-04 | 6 | 176 | 2 | cv:C1955869 | |
| Disease | Lissencephaly | 5.22e-04 | 6 | 176 | 2 | cv:C0266463 | |
| Disease | cerebral white matter volume change measurement, age at assessment | 6.12e-04 | 28 | 176 | 3 | EFO_0008007, EFO_0021499 | |
| Disease | longevity, healthspan, parental longevity | 6.80e-04 | 29 | 176 | 3 | EFO_0004300, EFO_0007796, EFO_0009762 | |
| Disease | leukemia (is_marker_for) | 7.28e-04 | 7 | 176 | 2 | DOID:1240 (is_marker_for) | |
| Disease | breast cancer (is_marker_for) | 8.80e-04 | 185 | 176 | 6 | DOID:1612 (is_marker_for) | |
| Disease | Leigh syndrome | 9.67e-04 | 8 | 176 | 2 | cv:C0023264 | |
| Disease | alcoholic hepatitis (is_marker_for) | 9.67e-04 | 8 | 176 | 2 | DOID:12351 (is_marker_for) | |
| Disease | microcephaly (is_implicated_in) | 9.67e-04 | 8 | 176 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | diffuse large B-cell lymphoma (is_marker_for) | 9.67e-04 | 8 | 176 | 2 | DOID:0050745 (is_marker_for) | |
| Disease | phosphatidylcholine 38:5 measurement | 9.98e-04 | 33 | 176 | 3 | EFO_0010387 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.15e-03 | 195 | 176 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | coronary aneurysm | 1.19e-03 | 35 | 176 | 3 | EFO_1000881 | |
| Disease | multiple myeloma (is_marker_for) | 1.29e-03 | 36 | 176 | 3 | DOID:9538 (is_marker_for) | |
| Disease | osteoarthritis, hand | 1.40e-03 | 37 | 176 | 3 | EFO_1000789 | |
| Disease | Intellectual Disability | 1.52e-03 | 447 | 176 | 9 | C3714756 | |
| Disease | Congenital myasthenic syndrome | 1.54e-03 | 10 | 176 | 2 | cv:C0751882 | |
| Disease | hair colour measurement, eye colour measurement, skin pigmentation measurement | 1.54e-03 | 10 | 176 | 2 | EFO_0007009, EFO_0007822, EFO_0009764 | |
| Disease | interventricular septum thickness | 1.54e-03 | 10 | 176 | 2 | EFO_0009287 | |
| Disease | migraine disorder, Headache | 1.78e-03 | 86 | 176 | 4 | HP_0002315, MONDO_0005277 | |
| Disease | pigmentation disease (is_implicated_in) | 1.88e-03 | 11 | 176 | 2 | DOID:10123 (is_implicated_in) | |
| Disease | prostatic hypertrophy (is_marker_for) | 1.88e-03 | 11 | 176 | 2 | DOID:11132 (is_marker_for) | |
| Disease | platelet component distribution width | HBS1L NPEPPS GRK5 TUBA1C LAMA5 PRDX2 ITGA2B TUBA4A NOL4L TRPM3 ATAD2B DNM3 | 2.00e-03 | 755 | 176 | 12 | EFO_0007984 |
| Disease | Malignant neoplasm of breast | TBXAS1 HK3 DSC3 PPM1E SH2D3A OBSCN BGN THBS1 KMT2D UNC45B AFP SLC6A5 RIC8A TIMELESS HERC2 | 2.03e-03 | 1074 | 176 | 15 | C0006142 |
| Disease | eye color | 2.10e-03 | 90 | 176 | 4 | EFO_0003949 | |
| Disease | schizophrenia, type 2 diabetes mellitus | 2.16e-03 | 43 | 176 | 3 | MONDO_0005090, MONDO_0005148 | |
| Disease | hair colour measurement, hair morphology measurement | 2.24e-03 | 12 | 176 | 2 | EFO_0007821, EFO_0007822 | |
| Disease | prostate cancer (is_marker_for) | 2.49e-03 | 156 | 176 | 5 | DOID:10283 (is_marker_for) | |
| Disease | autoimmune thrombocytopenic purpura (is_marker_for) | 2.64e-03 | 13 | 176 | 2 | DOID:8924 (is_marker_for) | |
| Disease | colon carcinoma (is_marker_for) | 2.64e-03 | 13 | 176 | 2 | DOID:1520 (is_marker_for) | |
| Disease | creatinine measurement | SFMBT1 OBSCN GLIS3 NSD1 LAMA5 CHD9 CARD10 FAM227B BTAF1 GIPR IGF2R DPF3 MITF NOCT | 2.67e-03 | 995 | 176 | 14 | EFO_0004518 |
| Disease | Endometrioma | 2.86e-03 | 161 | 176 | 5 | C0269102 | |
| Disease | Endometriosis | 2.86e-03 | 161 | 176 | 5 | C0014175 | |
| Disease | actinic keratosis | 3.07e-03 | 14 | 176 | 2 | EFO_0002496 | |
| Disease | pulmonary emphysema (is_marker_for) | 3.07e-03 | 14 | 176 | 2 | DOID:9675 (is_marker_for) | |
| Disease | alpha fetoprotein measurement | 3.07e-03 | 100 | 176 | 4 | EFO_0010583 | |
| Disease | ocular hypertension, response to triamcinolone acetonide | 3.14e-03 | 49 | 176 | 3 | EFO_0006954, EFO_1001069 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 3.52e-03 | 169 | 176 | 5 | DOID:3908 (is_marker_for) | |
| Disease | intraocular pressure measurement | 3.63e-03 | 509 | 176 | 9 | EFO_0004695 | |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment | 3.66e-03 | 105 | 176 | 4 | EFO_0007788, EFO_0008007, EFO_0008343 | |
| Disease | Fibrosis, Liver | 3.66e-03 | 105 | 176 | 4 | C0239946 | |
| Disease | immature platelet count | 3.79e-03 | 106 | 176 | 4 | EFO_0803544 | |
| Disease | mortality | 3.88e-03 | 173 | 176 | 5 | EFO_0004352 | |
| Disease | hair colour measurement | 3.99e-03 | 615 | 176 | 10 | EFO_0007822 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 4.02e-03 | 16 | 176 | 2 | C0751885 | |
| Disease | Diabetic Angiopathies | 4.02e-03 | 16 | 176 | 2 | C0011875 | |
| Disease | Urticaria | 4.02e-03 | 16 | 176 | 2 | C0042109 | |
| Disease | Microangiopathy, Diabetic | 4.02e-03 | 16 | 176 | 2 | C0025945 | |
| Disease | cathepsin L1 measurement | 4.02e-03 | 16 | 176 | 2 | EFO_0010619 | |
| Disease | anxiety measurement | 4.05e-03 | 108 | 176 | 4 | EFO_0009863 | |
| Disease | Pneumonia | 4.14e-03 | 54 | 176 | 3 | C0032285 | |
| Disease | Lobar Pneumonia | 4.14e-03 | 54 | 176 | 3 | C0032300 | |
| Disease | Pneumonitis | 4.14e-03 | 54 | 176 | 3 | C3714636 | |
| Disease | Experimental Lung Inflammation | 4.14e-03 | 54 | 176 | 3 | C0887898 | |
| Disease | hemoglobin A1 measurement | 4.16e-03 | 520 | 176 | 9 | EFO_0007629 | |
| Disease | clonal hematopoiesis mutation measurement | 4.36e-03 | 55 | 176 | 3 | EFO_0020949 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 4.54e-03 | 17 | 176 | 2 | C0751883 | |
| Disease | body surface area | 5.43e-03 | 643 | 176 | 10 | EFO_0022196 | |
| Disease | Brain Ischemia | 5.56e-03 | 60 | 176 | 3 | C0007786 | |
| Disease | Cerebral Ischemia | 5.56e-03 | 60 | 176 | 3 | C0917798 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 5.66e-03 | 19 | 176 | 2 | C0751884 | |
| Disease | skin sensitivity to sun | 5.66e-03 | 19 | 176 | 2 | EFO_0004795 | |
| Disease | age at onset, smoking initiation | 5.66e-03 | 19 | 176 | 2 | EFO_0004847, EFO_0005670 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ECITENFSIDPARTL | 601 | Q6ZT62 | |
| PDRENQDCLFDRISE | 216 | Q96M60 | |
| FCTRVDPLTLRDLDR | 746 | Q9BWT7 | |
| DARTERILSDLLPFC | 801 | Q92888 | |
| PVDVTDTLRCFRETL | 1866 | Q96N23 | |
| CEDAFTLTIPQFRES | 601 | Q63HQ2 | |
| VNRRPCFSALEVDET | 506 | P02768 | |
| ERNFLRCEDRPVVFT | 101 | Q6P1X6 | |
| DFEEALRNPDRLCIS | 46 | Q32M84 | |
| IDTIPELSRFTACID | 46 | Q8IZF6 | |
| RDSPCNSFAIKEIRD | 1096 | Q8N7X0 | |
| AQCFLSLERPRAEEA | 991 | Q07092 | |
| FRLLDDLVTCASRNP | 291 | Q9NPY3 | |
| RYRRECQETLAAAEP | 41 | P48546 | |
| FVHRLPCRDDDSVTA | 116 | Q14161 | |
| RNRVCFLDDEVTVPL | 406 | Q4L235 | |
| RVFTDVPSNCRELRL | 486 | O15484 | |
| RTDREKALCPTRENF | 1596 | Q9UPY3 | |
| QRLISSSCRLFFPED | 16 | Q8IUZ5 | |
| SRQDCPDSLADFREE | 611 | O95450 | |
| QERPVLCRTADDSFG | 996 | O95450 | |
| TELGRETDAFVCRPN | 656 | Q8WWK9 | |
| AFPLETHRSRVACVE | 1381 | Q149M9 | |
| FREGRVEQVPCSRAD | 266 | P24386 | |
| DNLSPEERDARTVFC | 156 | Q86U06 | |
| RVQIFTADLSEIPRC | 1881 | Q96L73 | |
| EIPRSAFECREQVVS | 631 | P20702 | |
| RCDVPSFSVQEELDF | 1031 | P20702 | |
| FTSPRAVEAAELCLE | 61 | P10746 | |
| ILRCVSDESLPFDLR | 761 | Q14571 | |
| QRSIDKPFRLCVSDV | 481 | Q9Y450 | |
| VFRLPTDLTACDNRL | 101 | Q96RS6 | |
| LSAAEDITPRFRAAC | 66 | Q9BUH6 | |
| DITPRFRAACEQQAV | 71 | Q9BUH6 | |
| RRVLCFDSTTAPVAN | 1061 | Q14207 | |
| RDAFSCTVPDELLNR | 161 | Q96LL4 | |
| ALVSATPREDFRVRC | 26 | Q96IY1 | |
| CDAPQDSRIFLVSVE | 1341 | O75147 | |
| DREETPSFLITCRAL | 116 | P32926 | |
| SLCNFSPLARRVDRV | 14391 | Q8WXI7 | |
| DFTFECNCLPETVRR | 241 | P0DPK3 | |
| LQCRDLLRATVFPET | 686 | Q14667 | |
| CAREVDANRPSTAFL | 216 | Q96JG8 | |
| RSLPRFQVTLCFGEE | 376 | Q15306 | |
| RGSPDITCVFLNVER | 166 | O43824 | |
| NPERSLEEDCFEVTR | 266 | Q96H55 | |
| LCAERSVRLPFLDSQ | 31 | Q92784 | |
| EFDRQCSTERRHDPL | 3641 | O95714 | |
| SELREFPAAARELCV | 11 | P0C870 | |
| TPEESCAQIFREARR | 811 | Q9ULI0 | |
| RSPRESLDDLFQICS | 711 | Q9UPZ3 | |
| VSQRRVDFCKDPSAI | 256 | P55212 | |
| EEFCNRSCEVPTRLN | 91 | P08174 | |
| LANFPRLCEETERIV | 446 | Q9UQ16 | |
| PVESCDRRFSRSDEL | 341 | P18146 | |
| VCRHDREPSFNETFR | 5071 | Q9Y6V0 | |
| FEPAARRASNICDTD | 896 | Q96RV3 | |
| ACERADEPQRFAADL | 546 | Q9UIW2 | |
| EQPEVFASACALARA | 116 | Q8NDH3 | |
| EVQPATFRCVTDRLA | 346 | P21810 | |
| ECSRVIADRFITPED | 2691 | Q96JB1 | |
| LASSEYPVRRRQCEE | 231 | P51570 | |
| DCPRLAISAREFVSD | 146 | O60662 | |
| ARCIRERDFPSFAQL | 241 | P53602 | |
| FLALCRARVRAQEPE | 11 | P07942 | |
| RRPASDIRVFASNCS | 11 | Q9UHC3 | |
| PVESCVRSFARSDEL | 486 | Q05215 | |
| LDVRECEQFARSGPV | 701 | Q9Y2D4 | |
| FSRCLELLFRATPEE | 476 | O15287 | |
| ERTFQLDTAVDRPCA | 2916 | O15230 | |
| VTQFEATDARRAFPC | 176 | A6NEC2 | |
| VELQCSRDSRDCPFL | 171 | Q9UKK3 | |
| RQEVSFNCIDEPSRC | 976 | Q13219 | |
| ESCSRQFPEFQERAR | 221 | Q96MY1 | |
| RELAPRCVVTFLQSE | 886 | P52790 | |
| CPTEIIAFSNRAEDF | 51 | P32119 | |
| FELVPDDERQCSACR | 666 | P29375 | |
| SRRAADIIECFSVPV | 636 | O14522 | |
| DPAEALCRAFRVTDE | 301 | Q8WY54 | |
| RCDVPSFSVQEELDF | 1026 | Q13349 | |
| RELQSVVLSCDFRPA | 2481 | Q5VST9 | |
| IPTEEERRVFAECND | 26 | Q9NX40 | |
| TIFCLETLPEFREDR | 231 | Q16322 | |
| ILSACSPFFTERLER | 51 | B2RXH4 | |
| DSFCDPFLISDELRR | 131 | Q9BRQ4 | |
| VCSPFTAARRLRDQE | 46 | P27469 | |
| AVLEECTSFIPEARA | 221 | Q5EBM0 | |
| RDATACYDRAIQLEP | 1716 | Q13535 | |
| NTIRADPALCFLERV | 1696 | Q3L8U1 | |
| CRQPSDSSVDKFVLR | 636 | P42858 | |
| IDAEPFIRCSLQCRD | 236 | Q53G59 | |
| LIICNEEFDSIPRRT | 166 | P29466 | |
| ECFRSADLIRSSDPD | 56 | Q14574 | |
| PTTERLNFDRFDICR | 96 | O14981 | |
| FSDPLCRSRLVDFQT | 256 | O60609 | |
| DFELNPTRVGCVDTR | 1516 | P35555 | |
| EDATFLQISTVDRCP | 751 | Q8NEA6 | |
| QDLPVRSEFELDRIC | 16 | Q8WTQ1 | |
| VVTLDPTRDQCFGDR | 236 | Q4ZIN3 | |
| FRLSPQGTRCIDVDE | 576 | Q8N2S1 | |
| ETAPQFTLLIRARDC | 236 | Q8IXH8 | |
| NDARLLSDAARIVCP | 91 | O95620 | |
| ARFCTRVSDTEFQPL | 696 | Q13683 | |
| FPHISQCEDLRRTID | 36 | P34947 | |
| SEDRSICLQPRLHFD | 321 | Q9UKT8 | |
| DSDCRDNAPRTIFII | 71 | Q14116 | |
| AIDSREDPVSCAFVV | 71 | P31944 | |
| TEEGEENPFICSSRR | 281 | O95180 | |
| ELDRRVCSEQAEPSF | 981 | Q9C0D2 | |
| NCPETRRLLEDAFFR | 31 | Q14147 | |
| PAVVERSDNFCRAGL | 91 | Q8NEC7 | |
| VTQFEATDARRAFPC | 176 | P55786 | |
| PCRAVFREAEVTLEA | 26 | P22223 | |
| QRDFVDLRTDCPSTH | 126 | Q9UK39 | |
| ANRRPCFSSLVVDET | 506 | P02771 | |
| VTAPEDTRRICELLF | 231 | O15305 | |
| TPRATLITFLCDRDA | 721 | P11717 | |
| DCTFQAQRKREDLSP | 976 | Q9P2F6 | |
| LERICQELTAAARPF | 181 | Q9BW92 | |
| NLTRIRPDCFLEVAD | 1126 | P26640 | |
| EPVLTCFNDADSRLR | 96 | Q08AM6 | |
| ERVRNCAALPRDFID | 596 | Q8IYL2 | |
| CLRPFTRESLAAIEQ | 16 | P35499 | |
| FCRAELDSEPERVAS | 786 | Q9P0V3 | |
| VSPLRFRCTECQDIE | 16 | Q86TJ2 | |
| TFQSADARACEAERP | 61 | Q9Y345 | |
| DFLDRNTPVFRDDVC | 421 | Q06210 | |
| FEEAALTRRICNPTS | 246 | Q6UX01 | |
| DAVLLCFDISRPETV | 86 | Q92730 | |
| DARFIRRSCTPNAEV | 346 | Q9C0A6 | |
| PGSVRFDCELRAVQV | 931 | O75592 | |
| AADCESPREFRERAL | 176 | Q8TF30 | |
| DERFPACIRDAVSQV | 61 | P57073 | |
| CPSLLFDLRDETRNV | 96 | P08514 | |
| FNPREATEAVILTCD | 156 | Q13046 | |
| RILSRDRNCLDPFTS | 71 | Q9NPQ8 | |
| LFSELTRPEFVVDCR | 1646 | O60287 | |
| ATLRCVRDPQRSFAL | 601 | Q96BD0 | |
| EDRVCFVATVRLATP | 246 | O15516 | |
| AEHLCRSPDIFSEQR | 296 | Q9C0C6 | |
| ALQRLCRASAETPAE | 801 | P42695 | |
| TCSFNSPLFRQEDDR | 6 | Q9UQ49 | |
| CLTDVRQALAAPRVA | 421 | Q9UID3 | |
| DICRRNLDIERPTYT | 211 | P0DPH8 | |
| ERCQPRSFLRDLVET | 491 | Q9UNS1 | |
| AFKDVQRCATLEPRN | 96 | Q8IWX7 | |
| PAFRFTREAAQDCEV | 406 | P24557 | |
| CPENVDISETDFRRF | 946 | P07996 | |
| TRLPEFSELQGCFRE | 501 | Q03169 | |
| CDANLHSRFPAERDI | 26 | Q8TCW7 | |
| RPEVTLCDRSCSFNE | 56 | Q7RTX1 | |
| EPAFREAAEEACRSI | 131 | Q99797 | |
| ELTACIFPTESEARA | 291 | O75030 | |
| QRRIDPSLDTFLERC | 326 | Q13129 | |
| LRDAIFCENTEPRSL | 851 | Q9Y5W7 | |
| TPIIESRARFCLSAA | 501 | O15270 | |
| VFESPNLAAVEICRD | 91 | Q9HAI6 | |
| EENRCFTRPQAEISF | 266 | Q9BRG2 | |
| SSAFLECEPRSLQAR | 586 | Q13214 | |
| IDTRCVNAPQAIADR | 1576 | Q9HCF6 | |
| RAFGVRLEECQPATE | 901 | Q9P227 | |
| DICRRNLDIERPTYT | 211 | P0DPH7 | |
| PNCRDFVTTAEDRSL | 241 | Q9Y263 | |
| DVVCFDAAPDATRRL | 181 | Q9C0B7 | |
| PLSFAACVNSEEIVR | 206 | Q9H1D0 | |
| LCAERSVRLPFLDSQ | 31 | Q92785 | |
| DVRRLCPDISFFQRA | 126 | Q9NVG8 | |
| LSPNFREAVTLSRDC | 41 | Q8N4Q0 | |
| RLDAPFCAAVRISQE | 1071 | Q8N398 | |
| CSSNAIRFVPDLEDI | 936 | Q2M389 | |
| RSTDCAPLARIFLDQ | 806 | Q9UHJ3 | |
| DICRRNLDIERPTYT | 211 | Q71U36 | |
| PDELAFRSCSEIRSA | 756 | Q9H7P9 | |
| DICRRNLDIERPTYT | 211 | Q6PEY2 | |
| LQTAFADARCFRDVP | 326 | Q00G26 | |
| TTRFPLHDREDEQLC | 286 | Q2TBF2 | |
| DICRRNLDIERPTYT | 211 | P68363 | |
| DFTCRPESVLQRDDP | 26 | O95125 | |
| CRVTTEDPARSFQPD | 376 | P11498 | |
| DICRRNLDIERPTYT | 211 | Q9BQE3 | |
| ELVRAQVPFSSCLEA | 521 | P45974 | |
| DICRRNLDIERPTYT | 211 | Q9NY65 | |
| DICRRNLDIERPTYT | 211 | P68366 | |
| RVTFSDDIRRICLPE | 281 | Q6ZMR5 | |
| DDIRRICLPEASASF | 286 | Q6ZMR5 | |
| PLSFAACVNSEEIVR | 166 | Q9NQA5 | |
| NPSLEDQACDRIYRV | 1091 | Q9UNY4 | |
| DILFLFRTPECARRS | 706 | B1ANS9 | |
| PCEQELSSFAVFRRV | 5141 | O14686 | |
| CIKPNDDREALQFSR | 956 | Q8WXR4 | |
| EEQLSPRSRVFASCA | 386 | Q9UL68 |